Literature DB >> 25078918

Commutability of the Epstein-Barr virus WHO international standard across two quantitative PCR methods.

Janaki Abeynayake1, Ryan Johnson1, Paolo Libiran2, Malaya K Sahoo1, Hongbin Cao3, Raffick Bowen1, K C Allen Chan4, Quynh-Thu Le3, Benjamin A Pinsky5.   

Abstract

The commutability of international reference standards is critical for ensuring quantitative agreement across different viral load assays. Here, we demonstrate the commutability of the Epstein-Barr virus (EBV) WHO international standard for the BamHI-W and artus EBV assays.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Year:  2014        PMID： 25078918      PMCID： PMC4187779          DOI： 10.1128/JCM.01676-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.

Authors:  Y M Lo; L Y Chan; K W Lo; S F Leung; J Zhang; A T Chan; J C Lee; N M Hjelm; P J Johnson; D P Huang
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

2.  Commutability of calibration and control materials for serum lipase.

Authors:  G Cattozzo; C Franzini; G M Melzi d'Eril
Journal:  Clin Chem       Date:  2001-12       Impact factor: 8.327

3.  Multicenter evaluation of a commercial cytomegalovirus quantitative standard: effects of commutability on interlaboratory concordance.

Authors:  R T Hayden; M D Shahbazian; A Valsamakis; J Boonyaratanakornkit; L Cook; X L Pang; J K Preiksaitis; E R Schönbrunner; A M Caliendo
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

4.  Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma.

Authors:  Anthony T C Chan; Y M Dennis Lo; Benny Zee; Lisa Y S Chan; Brigette B Y Ma; Sing-Fai Leung; Frankie Mo; Maria Lai; Stephen Ho; Dolly P Huang; Philip J Johnson
Journal:  J Natl Cancer Inst       Date:  2002-11-06       Impact factor: 13.506

5.  Factors contributing to variability of quantitative viral PCR results in proficiency testing samples: a multivariate analysis.

Authors:  R T Hayden; X Yan; M T Wick; A B Rodriguez; X Xiong; C C Ginocchio; M J Mitchell; A M Caliendo
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

Review 6.  Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.

Authors:  Margaret L Gulley; Weihua Tang
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

7.  Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen.

Authors:  S J Stevens; I Pronk; J M Middeldorp
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

8.  Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus.

Authors:  R T Hayden; K M Hokanson; S B Pounds; M J Bankowski; S W Belzer; J Carr; D Diorio; M S Forman; Y Joshi; D Hillyard; R L Hodinka; M N Nikiforova; C A Romain; J Stevenson; A Valsamakis; H H Balfour
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

9.  Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma.

Authors:  Jin-Ching Lin; Wen-Yi Wang; Kuang Y Chen; Yau-Huei Wei; Wen-Miin Liang; Jian-Sheng Jan; Rong-San Jiang
Journal:  N Engl J Med       Date:  2004-06-10       Impact factor: 91.245

10.  Accuracy verification and identification of matrix effects. The College of American Pathologists' Protocol.

Authors:  J H Eckfeldt; K R Copeland
Journal:  Arch Pathol Lab Med       Date:  1993-04       Impact factor: 5.534
View more
  13 in total

1.  Multicenter Evaluation of Whole-Blood Epstein-Barr Viral Load Standardization Using the WHO International Standard.

Authors:  Touyana Semenova; Julien Lupo; Sophie Alain; Gwladys Perrin-Confort; Laurence Grossi; Julie Dimier; Olivier Epaulard; Patrice Morand; Raphaële Germi
Journal:  J Clin Microbiol       Date:  2016-04-13       Impact factor: 5.948

2.  Progress in Quantitative Viral Load Testing: Variability and Impact of the WHO Quantitative International Standards.

Authors:  R T Hayden; Y Sun; L Tang; G W Procop; D R Hillyard; B A Pinsky; S A Young; A M Caliendo
Journal:  J Clin Microbiol       Date:  2016-11-16       Impact factor: 5.948

3.  Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer.

Authors:  Kelly Y Kim; Quynh-Thu Le; Sue S Yom; Benjamin A Pinsky; Scott V Bratman; Raymond H W Ng; Haja S El Mubarak; K C Allen Chan; Miriam Sander; Barbara A Conley
Journal:  J Natl Cancer Inst       Date:  2017-04-01       Impact factor: 13.506

4.  Calibration of BK Virus Nucleic Acid Amplification Testing to the 1st WHO International Standard for BK Virus.

Authors:  Susanna K Tan; Stephen Milligan; Malaya K Sahoo; Nathaniel Taylor; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2017-01-04       Impact factor: 5.948

5.  Matrix Matters: Assessment of Commutability among BK Virus Assays and Standards.

Authors:  R T Hayden; Y Su; J Boonyaratanakornkit; L Cook; Z Gu; K R Jerome; B A Pinsky; S S Sam; S K Tan; H Zhu; L Tang; A M Caliendo
Journal:  J Clin Microbiol       Date:  2022-08-23       Impact factor: 11.677

6.  Lymph-node Epstein-Barr virus concentration in diagnosing cervical lymph-node metastasis in nasopharyngeal carcinoma.

Authors:  HuiFang Li; Can Huang; Qiuyan Chen; Chuan Peng; Rong Zhang; Jingxian Shen; Mingyuan Chen; Haiqiang Mai; Ruhai Zou
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-04-02       Impact factor: 2.503

7.  Transplant Virus Detection Using Multiplex Targeted Sequencing.

Authors:  Susanna K Tan; Peidong Shen; Martina I Lefterova; Malaya K Sahoo; Eula Fung; Justin I Odegaard; Ronald W Davis; Benjamin A Pinsky; Curt Scharfe
Journal:  J Appl Lab Med       Date:  2018-03

8.  Metagenomic Next-Generation Sequencing for Identification and Quantitation of Transplant-Related DNA Viruses.

Authors:  Meredith L Carpenter; Susanna K Tan; Thomas Watson; Rowena Bacher; Vaishnavi Nagesh; Alain Watts; Gordon Bentley; Jenna Weber; ChunHong Huang; Malaya K Sahoo; Armin Hinterwirth; Thuy Doan; Theodore Carter; Queeny Dong; Stéphane Gourguechon; Eric Harness; Sean Kermes; Srihari Radhakrishnan; Gongbo Wang; Alejandro Quiroz-Zárate; Jesus Ching; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

9.  Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area.

Authors:  Salvatore Alfieri; Nicola Alessandro Iacovelli; Sara Marceglia; Irene Lasorsa; Carlo Resteghini; Francesca Taverna; Arabella Mazzocchi; Ester Orlandi; Marco Guzzo; Roberto Bianchi; Diana Fanti; Laura Pala; Sara Racca; Roee Dvir; Pasquale Quattrone; Annunziata Gloghini; Chiara Costanza Volpi; Roberta Granata; Cristiana Bergamini; Laura Locati; Lisa Licitra; Paolo Bossi
Journal:  Oncotarget       Date:  2017-07-18

10.  The impact of targeting repetitive BamHI-W sequences on the sensitivity and precision of EBV DNA quantification.

Authors:  Armen Sanosyan; Alexis Fayd'herbe de Maudave; Karine Bollore; Valérie Zimmermann; Vincent Foulongne; Philippe Van de Perre; Edouard Tuaillon
Journal:  PLoS One       Date:  2017-08-29       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.